A Study of Perjeta (Pertuzumab) in Combination With Herceptin (Trastuzumab) in Participants With Metastatic Breast Cancer
Clinical trial NCT01674062 · COMPLETED
Trial details
- NCT number
- NCT01674062
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2008-02-01
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.